Prostamax

Prostamax — Prostate Peptide Bioregulator

Prostamax is a short synthetic peptide bioregulator with the sequence Lys-Glu-Asp-Pro (KEDP). Part of the Khavinson tissue-specific peptide program, it is researched for proposed regulatory activity in prostate tissue, with interest in prostatic inflammation and male-aging research models.

Mechanism of Action

As an ultrashort peptide bioregulator of the Khavinson class, Prostamax is studied for a non-receptor, epigenetic-style mechanism. The peptide is small enough to be proposed to cross the cell and nuclear membranes and interact directly with DNA and chromatin, modulating the tissue-specific expression of genes associated with prostate epithelial cells. This differs fundamentally from receptor-signaling peptides — the proposed activity is regulation of transcription rather than activation of a cell-surface receptor. Evidence is preclinical (cell-culture and animal models) from the originating research program.

Available Formats

• 20mg

Reconstitution: Reconstitute with Bacteriostatic Water (BAC Water) for multi-use stability, or Sterile Water for single-use protocols. Store lyophilized vials refrigerated at 2–8°C, protected from light.

Key Research Areas

♂️ Prostatic Inflammation

Studied in preclinical models for markers of prostate inflammation and tissue quality.

♂️ Age-Related Prostate Change

Investigated in the context of male aging and prostate-tissue degradation.

🔬 Urinary-Function Research

Examined for endpoints tied to prostate-related urinary parameters in research models.

⏳ Male Aging

Part of the broader Khavinson tissue-specific bioregulation research program.

FOR RESEARCH USE ONLY (RUO). This product is not a drug, food, or cosmetic and is not approved for human or veterinary use. All statements describe proposed or preclinical research findings only. Intended strictly for in vitro and laboratory research by qualified professionals. EhBuddy Peptides assumes no liability for misuse.